Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...

With a HCPCS code and two major distribution agreements in hand, Signifier Medical Technologies is creating a path for itself and sleep stakeholders looking for an alternative to CPAP ...

Do you experience an inclination for snoring, daytime sleepiness, obesity, high blood pressure, impaired concentration and ...

For about 25 million Americans who suffer from obstructive sleep apnea, there are various effective treatments such as CPAP breathing machines, surgery, a dental mouthpiece and even an implantable pac ...

Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...

Peer Support Could Help Millions With Sleep Apnea Slumber Easier, Study Says Dec. 4, 2024 — Continuous positive airway pressure, or CPAP, therapy can improve the lives of people with obstructive ...

The U.S. FDA has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea.

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

July 23, 2024 — Nearly 40 million adults in the U.S. have sleep apnea, and more than 30 million of them use a continuous positive airway pressure (CPAP) machine while sleeping. However ...

Eli Lilly's (NYSE:LLY) weight-loss drug Zepbound is now reportedly covered by Medicare for the treatment of obstructive sleep ...